refractory anemia with ringed sideroblasts
Showing 1 - 25 of >10,000
AML, ALL, Undifferentiated Leukemia Trial in Boston (Abatacept)
Completed
- AML
- +11 more
-
Boston, MassachusettsBoston Children's Hospital
Oct 31, 2019
Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With
Active, not recruiting
- Adult Acute Lymphoblastic Leukemia in Remission
- +46 more
- Fludarabine
- +8 more
-
Philadelphia, PennsylvaniaThomas Jefferson University
Feb 10, 2021
Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Adult Acute Lymphoblastic Leukemia in Remission, Adult
Terminated
- Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
- +9 more
- Allogeneic Bone Marrow Transplantation
- +7 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Oct 4, 2021
Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid
Completed
- Adult Acute Myeloid Leukemia in Remission
- +16 more
- iodine I 131 monoclonal antibody BC8
- +7 more
-
Seattle, WashingtonFred Hutchinson Cancer Research Center/University of Washington
Nov 8, 2019
Cancer in Inherited Bone Marrow Failure Syndromes
Recruiting
- Diamond Blackfan Anemia
- +4 more
-
Bethesda, Maryland
- +1 more
Jan 24, 2023
Adult Acute Myeloid Leukemia in Remission, Childhood Acute Lymphoblastic Leukemia in Remission, Childhood Acute Myeloid Leukemia
Completed
- Adult Acute Myeloid Leukemia in Remission
- +29 more
- Fludarabine Phosphate
- +5 more
-
Tucson, Arizona
- +9 more
Dec 18, 2019
Chronic Myelomonocytic Leukemia, de Novo MDS, MDS Trial in Cleveland (other, drug, genetic)
Completed
- Chronic Myelomonocytic Leukemia
- +7 more
- flow cytometry
- +7 more
-
Cleveland, Ohio
- +1 more
Feb 21, 2019
Mean Platelet Volume and Its Relation to Risk Stratification of
Completed
- Myelodysplastic Syndromes
- (no location specified)
Jan 21, 2022
MDS (MDS) Trial in United States (Alvocidib Plus Decitabine (during dose escalation only) or Azacitidine)
Completed
- Myelodysplastic Syndromes (MDS)
- Alvocidib Plus Decitabine (during dose escalation only) or Azacitidine
-
Chicago, Illinois
- +11 more
Apr 4, 2022
MDS Trial in Beijing (Roxadustat, Luspatercept)
Not yet recruiting
- Myelodysplastic Syndromes
-
Beijing, ChinaPeking union medical college hospital
Aug 17, 2023
Primary Myelofibrosis, Polycythemia Vera, Essential Thrombocythemia Trial in Toronto (Observational)
Recruiting
- Primary Myelofibrosis
- +9 more
- Observational
-
Toronto, Ontario, CanadaPrincess Margaret Cancer Centre
Apr 11, 2022
Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative, Chronic Myelomonocytic Leukemia, de Novo Myelodysplastic Syndrome Trial in
Completed
- Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative
- +13 more
- Cyclosporine
- +6 more
-
Salt Lake City, Utah
- +2 more
Jan 15, 2020
MDS, Anemia Trial in Germany (Luspatercept Injection)
Recruiting
- Myelodysplastic Syndromes
- Anemia
- Luspatercept Injection
-
Berlin, Germany
- +18 more
Jan 25, 2023
MDS, Del(5Q), Anemia Trial in Italy (Luspatercept Injection [Reblozyl])
Recruiting
- Myelodysplastic Syndromes
- +3 more
- Luspatercept Injection [Reblozyl]
-
Alessandria, Italy
- +22 more
Jun 20, 2023
MDS Trial in Worldwide (Luspatercept, Placebo)
MDS Trial in Beijing (Lenalidomide, Azacitidine)
Not yet recruiting
- Myelodysplastic Syndromes
-
Beijing, ChinaPeking union medical college hospital
Aug 16, 2023
Myeloproliferative Disorders, Acute Myelogenous Leukemia, Chronic Myelogenous Leukemia Trial run by the NHLBI (T-cell replete
Completed
- Myeloproliferative Disorders
- +4 more
- T-cell replete PBPC allograft
- +3 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Oct 12, 2022
Myelodysplastic/Myeloproliferative Tumor With Ring Sideroblasts and Thrombocytosis, Myelodysplastic/Myeloproliferative Tumor,
Recruiting
- Myelodysplastic/Myeloproliferative Neoplasm With Ring Sideroblasts and Thrombocytosis
- Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable
- Hydroxyurea
- Luspatercept
-
Rochester, MinnesotaMayo Clinic in Rochester
Jan 6, 2023
Chronic Myeloproliferative Disorders, Leukemia, Multiple Myeloma and Malignant Plasma Cell Tumors Trial in Tampa (busulfan,
Completed
- Chronic Myeloproliferative Disorders
- +4 more
- busulfan
- +3 more
-
Tampa, FloridaH. Lee Moffitt Cancer Center and Research Institute at Universit
Dec 9, 2020
Leukemia, MDS, Myelodysplastic/Myeloproliferative Tumors Trial in United States (arsenic trioxide)
Terminated
- Leukemia
- +2 more
- arsenic trioxide
-
Tucson, Arizona
- +7 more
Oct 2, 2020
MDS, MDS Trial in France (Luspatercept Injection [Reblozyl], Eprex)
Recruiting
- MDS
- Myelodysplastic Syndromes
- Luspatercept Injection [Reblozyl]
- Eprex
-
Amiens, France
- +30 more
May 19, 2022
Leukemia, MDS Trial in Los Angeles (arsenic trioxide, azacitidine)
Terminated
- Leukemia
- Myelodysplastic Syndromes
- arsenic trioxide
- azacitidine
-
Los Angeles, CaliforniaJonsson Comprehensive Cancer Center at UCLA
Jul 29, 2020
Refractory Aplastic Anemia Trial in Tianjin (Decitabine)
Terminated
- Refractory Aplastic Anemia
-
Tianjin, Tianjin, ChinaRegenerative Medicine Center
Aug 25, 2022
Warm Autoimmune Hemolytic Anemia Trial in Beijing (Sirolimus)
Not yet recruiting
- Warm Autoimmune Hemolytic Anemia
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Jun 21, 2023